Lupin

Market Cap: Large Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE326A01037
NSEID: LUPIN
BSEID: 500257

INR

2,097.75

5.8 (0.28%)

BSENSE

Dec 05

BSE+NSE Vol: 2.86 lacs

{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,097.75",
    "chg": 5.8,
    "chgp": "0.28%",
    "dir": 1,
    "prev_price": "2,091.95",
    "mcapval": "95,817.29 Cr",
    "mcap": "Large Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE326A01037",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "2.86 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd: Technical Momentum Shift Signals Bullish Outlook Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-shares-gain-momentum-as-technical-indicators-signal-bullish-shift-3737479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Lupin_technicaldot_3737479.png",
        "date": "2025-12-01 08:02:41",
        "description": "Lupin Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, reflecting a more bullish stance in recent market assessments. Despite a year-to-date return that contrasts with broader market gains, the stock's technical indicators suggest evolving investor sentiment and potential opportunities ahead."
      },
      {
        "title": "Is Lupin technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lupin-technically-bullish-or-bearish-3736441",
        "imagepath": "",
        "date": "2025-11-29 08:17:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 28 November 2025, Lupin’s technical trend has upgraded from mildly bullish to bullish, signalling a positive shift in market sentiment. This change is significant as it reflects a consolidation of various technical indicators pointing towards upward momentum. The current price stands at ₹2,081, slightly above the previous close of ₹2,072.40, with intraday highs touching ₹2,091.25 and lows at ₹2,068.75. The stock remains comfortably above its 52-week low of ₹1,774.00, though still below the 52-week high of ₹2,403.45, indicating room for further upside.</p>\n<p><strong>Weekly and Monthly Technical Indicators</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD), the weekly chart shows a bullish signal, suggesting positive m..."
      },
      {
        "title": "Lupin Forms Golden Cross, Signalling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-forms-golden-cross-signalling-potential-bullish-breakout-3735944",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Lupin_goldencross_3735944.png",
        "date": "2025-11-28 18:00:21",
        "description": "Lupin, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical event where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential shift towards a bullish trend, indicating renewed investor confidence and a possible long-term momentum change for the stock."
      },
      {
        "title": "Lupin Sees Revision in Market Evaluation Amid Positive Financial Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-upgraded-to-buy-by-marketsmojo-on-strong-fundamentals-and-valuation-3730929",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Lupin_mojoScore_3730929.png",
        "date": "2025-11-26 09:46:39",
        "description": "Lupin, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trends, and technical positioning within a competitive large-cap environment."
      },
      {
        "title": "Lupin Ltd Sees Notable Surge in Open Interest Amid Rising Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-sees-significant-open-interest-surge-amid-bullish-market-momentum-3729205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Lupin_oi_spurts_by_underlying_3729205.png",
        "date": "2025-11-25 15:00:16",
        "description": "Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and evolving investor positioning. This development coincides with a positive price movement and increased trading volumes, reflecting a dynamic shift in market sentiment towards the stock."
      },
      {
        "title": "Lupin Ltd Sees Notable Surge in Open Interest Amidst Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-sees-significant-open-interest-surge-amid-mixed-market-signals-3725786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Lupin_oi_spurts_by_underlying_3725786.png",
        "date": "2025-11-24 15:00:52",
        "description": "Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of recent price fluctuations and increased trading volumes, prompting a closer examination of the underlying market dynamics and potential directional bets."
      },
      {
        "title": "Lupin Ltd Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-sees-sharp-open-interest-surge-amid-mixed-price-action-and-rising-investor-activity-3725649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Lupin_oi_spurts_by_underlying_3725649.png",
        "date": "2025-11-24 14:00:38",
        "description": "Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of recent price fluctuations and increased trading volumes, reflecting a complex interplay of market forces shaping the stock’s near-term outlook."
      },
      {
        "title": "Lupin Ltd Sees Notable Surge in Open Interest Amidst Narrow Trading Range",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-sees-significant-open-interest-surge-amidst-mixed-market-signals-3721290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Lupin_oi_spurts_by_underlying_3721290.png",
        "date": "2025-11-21 15:00:47",
        "description": "Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes alongside a narrow price range and mixed volume patterns, reflecting a complex interplay of market forces as participants recalibrate their strategies."
      },
      {
        "title": "Lupin Ltd Sees Notable Surge in Open Interest Amidst Narrow Trading Range",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amidst-derivatives-market-activity-3721155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Lupin_oi_spurts_by_underlying_3721155.png",
        "date": "2025-11-21 14:00:39",
        "description": "Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving positioning among traders. This development comes alongside a modest price movement and a narrow trading range, reflecting a complex interplay of market forces and investor sentiment."
      }
    ],
    "total": 560,
    "sid": "641789",
    "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
      "datetime": "01-Dec-2025",
      "details": "Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg (Pegfilgrastim-unne).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "28-Nov-2025",
      "details": "Lupin Foundation Earns CRISILs Highest VO 1A Rating for Excellence in Social Responsibility.",
      "source": "BSE"
    },
    {
      "caption": "U.S. FDA Has Conducted An Inspection At Companys Manufacturing Facility Located At Goa India.",
      "datetime": "21-Nov-2025",
      "details": "U.S. FDA has conducted an inspection at Companys manufacturing facility located at Goa India.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>600%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lupin Ltd: Technical Momentum Shift Signals Bullish Outlook Amid Mixed Market Returns

2025-12-01 08:02:41

Lupin Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, reflecting a more bullish stance in recent market assessments. Despite a year-to-date return that contrasts with broader market gains, the stock's technical indicators suggest evolving investor sentiment and potential opportunities ahead.

Is Lupin technically bullish or bearish?

2025-11-29 08:17:31

Recent Technical Trend Shift

As of 28 November 2025, Lupin’s technical trend has upgraded from mildly bullish to bullish, signalling a positive shift in market sentiment. This change is significant as it reflects a consolidation of various technical indicators pointing towards upward momentum. The current price stands at ₹2,081, slightly above the previous close of ₹2,072.40, with intraday highs touching ₹2,091.25 and lows at ₹2,068.75. The stock remains comfortably above its 52-week low of ₹1,774.00, though still below the 52-week high of ₹2,403.45, indicating room for further upside.

Weekly and Monthly Technical Indicators

Examining the Moving Average Convergence Divergence (MACD), the weekly chart shows a bullish signal, suggesting positive m...

Lupin Forms Golden Cross, Signalling Potential Bullish Breakout

2025-11-28 18:00:21

Lupin, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross, a significant technical event where the 50-day moving average crosses above the 200-day moving average. This development often signals a potential shift towards a bullish trend, indicating renewed investor confidence and a possible long-term momentum change for the stock.

Lupin Sees Revision in Market Evaluation Amid Positive Financial Indicators

2025-11-26 09:46:39

Lupin, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trends, and technical positioning within a competitive large-cap environment.

Lupin Ltd Sees Notable Surge in Open Interest Amid Rising Market Activity

2025-11-25 15:00:16

Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and evolving investor positioning. This development coincides with a positive price movement and increased trading volumes, reflecting a dynamic shift in market sentiment towards the stock.

Lupin Ltd Sees Notable Surge in Open Interest Amidst Market Volatility

2025-11-24 15:00:52

Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of recent price fluctuations and increased trading volumes, prompting a closer examination of the underlying market dynamics and potential directional bets.

Lupin Ltd Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-11-24 14:00:38

Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of recent price fluctuations and increased trading volumes, reflecting a complex interplay of market forces shaping the stock’s near-term outlook.

Lupin Ltd Sees Notable Surge in Open Interest Amidst Narrow Trading Range

2025-11-21 15:00:47

Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes alongside a narrow price range and mixed volume patterns, reflecting a complex interplay of market forces as participants recalibrate their strategies.

Lupin Ltd Sees Notable Surge in Open Interest Amidst Narrow Trading Range

2025-11-21 14:00:39

Lupin Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant rise in open interest in its derivatives segment, signalling heightened market activity and evolving positioning among traders. This development comes alongside a modest price movement and a narrow trading range, reflecting a complex interplay of market forces and investor sentiment.